Back to mobile site

DepoMed Inc (DEPO) PT Lowered to $6 at RBC Capital Following 3Q Miss

November 8, 2017 8:13 AM EST Send to a Friend
RBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $6.00 (from $8.00) while maintaining a Sector ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login